161 related articles for article (PubMed ID: 25164143)
1. Systemic anti-tumour effects of local thermally sensitive liposome therapy.
Viglianti BL; Dewhirst MW; Boruta RJ; Park JY; Landon C; Fontanella AN; Guo J; Manzoor A; Hofmann CL; Palmer GM
Int J Hyperthermia; 2014 Sep; 30(6):385-92. PubMed ID: 25164143
[TBL] [Abstract][Full Text] [Related]
2. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors.
Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH
J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227
[TBL] [Abstract][Full Text] [Related]
3. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and hyperthermic release of doxorubicin from liposomal doxorubicin hydrochloride in rabbit VX2 tumours.
Xiong P; Ding A; Su Z; Shen G; Chen Y; Zhang S
Int J Hyperthermia; 2015; 31(8):900-8. PubMed ID: 26726929
[TBL] [Abstract][Full Text] [Related]
5. Near-infrared light-sensitive liposomes for the enhanced photothermal tumor treatment by the combination with chemotherapy.
You J; Zhang P; Hu F; Du Y; Yuan H; Zhu J; Wang Z; Zhou J; Li C
Pharm Res; 2014 Mar; 31(3):554-65. PubMed ID: 24022681
[TBL] [Abstract][Full Text] [Related]
6. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
[TBL] [Abstract][Full Text] [Related]
7. Mild hyperthermia accelerates doxorubicin clearance from tumour-extravasated temperature-sensitive liposomes.
Al-Jamal WT; Kostarelos K
Nanotheranostics; 2022; 6(3):230-242. PubMed ID: 35145834
[TBL] [Abstract][Full Text] [Related]
8. Extensive preclinical investigation of polymersomal formulation of doxorubicin versus Doxil-mimic formulation.
Alibolandi M; Abnous K; Mohammadi M; Hadizadeh F; Sadeghi F; Taghavi S; Jaafari MR; Ramezani M
J Control Release; 2017 Oct; 264():228-236. PubMed ID: 28844758
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermia mediated liposomal drug delivery.
Ponce AM; Vujaskovic Z; Yuan F; Needham D; Dewhirst MW
Int J Hyperthermia; 2006 May; 22(3):205-13. PubMed ID: 16754340
[TBL] [Abstract][Full Text] [Related]
10. Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models.
Burade V; Bhowmick S; Maiti K; Zalawadia R; Ruan H; Thennati R
BMC Cancer; 2017 Jun; 17(1):405. PubMed ID: 28587612
[TBL] [Abstract][Full Text] [Related]
11. Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer.
Mikhail AS; Negussie AH; Pritchard WF; Haemmerich D; Woods D; Bakhutashvili I; Esparza-Trujillo J; Brancato SJ; Karanian J; Agarwal PK; Wood BJ
Int J Hyperthermia; 2017 Nov; 33(7):733-740. PubMed ID: 28540814
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours.
Yarmolenko PS; Zhao Y; Landon C; Spasojevic I; Yuan F; Needham D; Viglianti BL; Dewhirst MW
Int J Hyperthermia; 2010; 26(5):485-98. PubMed ID: 20597627
[TBL] [Abstract][Full Text] [Related]
13. Enhanced drug delivery in rabbit VX2 tumours using thermosensitive liposomes and MRI-controlled focused ultrasound hyperthermia.
Staruch RM; Ganguly M; Tannock IF; Hynynen K; Chopra R
Int J Hyperthermia; 2012; 28(8):776-87. PubMed ID: 23153219
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive monitoring of intra-tumor drug concentration and therapeutic response using optical spectroscopy.
Palmer GM; Boruta RJ; Viglianti BL; Lan L; Spasojevic I; Dewhirst MW
J Control Release; 2010 Mar; 142(3):457-64. PubMed ID: 19896999
[TBL] [Abstract][Full Text] [Related]
15. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
[TBL] [Abstract][Full Text] [Related]
16. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
[TBL] [Abstract][Full Text] [Related]
17. A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer.
Zhao Y; Alakhova DY; Kim JO; Bronich TK; Kabanov AV
J Control Release; 2013 May; 168(1):61-9. PubMed ID: 23474033
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of doxorubicin thermosensitive liposomes (40 degrees C) and local hyperthermia on rat rhabdomyosarcoma.
Morita K; Zywietz F; Kakinuma K; Tanaka R; Katoh M
Oncol Rep; 2008 Aug; 20(2):365-72. PubMed ID: 18636199
[TBL] [Abstract][Full Text] [Related]
19. Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer.
VanOsdol J; Ektate K; Ramasamy S; Maples D; Collins W; Malayer J; Ranjan A
J Control Release; 2017 Feb; 247():55-63. PubMed ID: 28042085
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast enhanced MRI detects changes in vascular transport rate constants following treatment with thermally-sensitive liposomal doxorubicin.
Fite BZ; Kheirolomoom A; Foiret JL; Seo JW; Mahakian LM; Ingham ES; Tam SM; Borowsky AD; Curry FE; Ferrara KW
J Control Release; 2017 Jun; 256():203-213. PubMed ID: 28395970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
